OverviewChartNewsTraderScreen

GARO AB/  SE0015812417  /

Stuttgart
5/17/2024  3:57:12 PM Chg. +0.065 Volume Bid10:00:01 PM Ask10:00:01 PM High Low
2.690EUR +2.48% 0
Turnover: 0.000		 -Bid Size: - -Ask Size: - 2.690 2.570
GlobeNewswire 3/7/2022 Targovax ASA and Agenus announce collaboration on mutant KRAS cancer vaccine adjuvanted with QS-21 S...
GlobeNewswire 11/17/2021 Agenus to Participate in 4th Annual Evercore ISI HealthCONx Conference
GlobeNewswire 11/16/2021 Protagenic Therapeutics Announces Third Quarter 2021 Results and Business Update
GlobeNewswire 11/9/2021 Agenus Corporate Update and Third Quarter 2021 Financial Report
GlobeNewswire 10/22/2021 Agenus Provides Update on Balstilimab Development
GlobeNewswire 9/10/2021 New Agenus Subsidiary, SaponiQx, Builds Innovative Adjuvant Platform and Forms Collaboration with Gi...
GlobeNewswire 8/17/2021 Protagenic Therapeutics Announces Second Quarter 2021 Results and Provides Business Update
GlobeNewswire 8/9/2021 Agenus Corporate Update and Second Quarter 2021 Financial Report
GlobeNewswire 7/10/2021 Agenus Acquires 120 Acres in the Heart of the California Biomanufacturing Center in Vacaville
GlobeNewswire 7/6/2021 Agenus Closes $200M Upfront BMS Collaboration and Announces FDA Acceptance of IND for Partnered Anti...
GlobeNewswire 5/18/2021 Agenus and Bristol Myers Squibb Announce Exclusive Global License for Agenus’ Anti-TIGIT Bispecific ...
GlobeNewswire 5/6/2021 Agenus Corporate Update and First Quarter 2021 Financial Report
GlobeNewswire 3/15/2021 Progress Software to Report First Quarter Financial Results on March 25, 2021
GlobeNewswire 3/15/2021 Agenus Corporate Update and Fourth Quarter & Full Year 2020 Financial Report
GlobeNewswire 2/9/2021 Andy Hurley Named Agenus Chief Commercial Officer
GlobeNewswire 2/4/2021 Agenus Announces Positive Preliminary Results of iNKT Cell Therapy Trial in COVID-19
GlobeNewswire 1/14/2021 Progress Reports 2020 Fiscal Fourth Quarter and Year End Results
GlobeNewswire 1/4/2021 Progress Software to Report Financial Results for Fiscal Fourth Quarter and Fiscal 2020 on January 1...
GlobeNewswire 12/16/2020 Dr. Maurizio Fava of Massachusetts General Hospital to Serve as Principal Investigator for PT00114 C...
GlobeNewswire 11/10/2020 An Agenus-discovered first-in-class ILT4 antibody, MK-4830, enters Phase 2
GlobeNewswire 11/5/2020 Dr. Steven O’Day Named Agenus Chief Medical Officer
GlobeNewswire 11/2/2020 Agenus Doses First COVID-19 Patient with iNKT Cell Therapy
GlobeNewswire 10/13/2020 Susan Hirsch Joins Agenus’ Board of Directors
GlobeNewswire 9/29/2020 Progress Announces Third Quarter 2020 Financial Results
GlobeNewswire 9/22/2020 Progress Software Announces Details for Fiscal Third Quarter Earnings Release and Conference Call